APP To Add New Pharmaceutical Jobs

APP Pharmaceuticals, a leading supplier of injectable pharmaceutical products in North America, has decided to invest $38 million in order to expand its Grand Island, New York manufacturing facility.The company, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, shared that the plan is to expand the manufacturing site by 13,000 square feet and also add an additional six production lines for injectable products. Expansion measures are anticipated to last two years, with work on the site beginning in June 2011.The move will also result in new Pharmaceutical Jobs.Currently, 580 people work at the Grand Island site and APP plans to hire an additional 90 employees within the scope of the site expansion.At its Grand Island facility, the company manufactures a variety of injectable pharmaceutical products for the North America market that encompasses four therapeutic areas: anti-infectives, critical care, analgesia/anesthesia and oncology. The expansion will increase APP’s manufacturing capabilities of injectable generics.The Grand Island facility forms part of a global supply chain network that provides pharmaceutical products to the US and Canada.Dr. Michael Schönhofen, President, Science, Production & Technology, Fresenius Kabi, said, “The investment in this facility is an important step within our production strategy. Through the expansion, the site will significantly contribute to the continuous local supply of high quality injectable generics for the US and Canada.”APP’s Grand Island plant obtained FDA certification that same year. The facility has been expanded a number of times, most recently in 2005 when the company enhanced the site’s manufacturing capability for aseptic filling and packaging, as well as for the production of oncology drugs.SupportIn addition, the company announced that Empire State Development will provide $1,187,763 in Excelsior Jobs Program tax credits over a five year period, while the New York Power Authority will assist with an allocation of 2,000 kW to bring the company’s power costs in line with other out-of-state locations. Erie County Economic Development Corporation will provide property tax, sales tax and mortgage tax abatements.“APP Pharmaceuticals will create good, quality jobs that will help expand the important life sciences sector of our economy and help Western New York continue its revitalization,” said Empire State Development President, CEO & Commissioner Kenneth Adams.